Literature DB >> 24445959

NLRC5 mediates cytokine secretion in RAW264.7 macrophages and modulated by the JAK2/STAT3 pathway.

Lin Li1, Tao Xu, Cheng Huang, Yunyun Peng, Jun Li.   

Abstract

The nucleotide-binding domain leucine-rich repeat proteins (NLRs), a class of innate immune receptors that respond to pathogen attack or cellular stress, have gained increasing attention. NLRC5 is the largest member of NLR family, which has recently been identified as a critical regulator of immune responses. In this study, we explore the role of NLRC5 in cytokine secretion and the role of the JAK2/STAT3 signaling pathway in lipopolysaccharide-induced NLRC5 expression in RAW264.7 cells. We demonstrated that overexpression of NLRC5 results in a downregulation of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) secretion; on the other hand, knockdown of NLRC5 by transfecting siRNA enhanced IL-6 and TNF-α secretion in RAW264.7 cells. These results indicated that NLRC5 plays a negative role in the regulation of IL-6 and TNF-α. Meanwhile, AG490 (a specific inhibitor of the JAK2/STAT3 signaling pathway) and JAK2 siRNA were used to manipulate JAK2/STAT3 activity. Finally, the results showed that AG490 and JAK2 siRNA inhibited NLRC5 expression and the expression levels of p-JAK2 and p-STAT3. We, for the first time, demonstrate that the inhibition of the JAK2/STAT3 signaling pathway results in decrease of NLRC5 expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24445959     DOI: 10.1007/s10753-013-9804-y

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  35 in total

1.  A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses.

Authors:  Andreas Neerincx; Katja Lautz; Maureen Menning; Elisabeth Kremmer; Paola Zigrino; Marianna Hösel; Hildegard Büning; Robert Schwarzenbacher; Thomas A Kufer
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner.

Authors:  Andreas Neerincx; Galaxia M Rodriguez; Viktor Steimle; Thomas A Kufer
Journal:  J Immunol       Date:  2012-04-06       Impact factor: 5.422

3.  JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma.

Authors:  Zhenbing You; Dafu Xu; Jian Ji; Wei Guo; Weiguo Zhu; Jingdong He
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

Review 4.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.

Authors:  Kenya Honda; Tadatsugu Taniguchi
Journal:  Nat Rev Immunol       Date:  2006-09       Impact factor: 53.106

Review 5.  Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.

Authors:  Michael Karin; Toby Lawrence; Victor Nizet
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

6.  IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.

Authors:  D M Rothwarf; E Zandi; G Natoli; M Karin
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

7.  NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.

Authors:  Jun Cui; Liang Zhu; Xiaojun Xia; Helen Y Wang; Xavier Legras; Jun Hong; Jiabing Ji; Pingping Shen; Shu Zheng; Zhijian J Chen; Rong-Fu Wang
Journal:  Cell       Date:  2010-04-30       Impact factor: 41.582

8.  NLR family member NLRC5 is a transcriptional regulator of MHC class I genes.

Authors:  Torsten B Meissner; Amy Li; Amlan Biswas; Kyoung-Hee Lee; Yuen-Joyce Liu; Erkan Bayir; Dimitrios Iliopoulos; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-16       Impact factor: 11.205

9.  Anti-inflammatory activity of baicalein in LPS-stimulated RAW264.7 macrophages via estrogen receptor and NF-κB-dependent pathways.

Authors:  Guan-Wei Fan; Yuan Zhang; Xiaorui Jiang; Yan Zhu; Bingyao Wang; Lina Su; Wenjie Cao; Han Zhang; Xiumei Gao
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

10.  NLRC5 knockdown in chicken macrophages alters response to LPS and poly (I:C) stimulation.

Authors:  Ling Lian; Ceren Ciraci; Guobin Chang; Jingdong Hu; Susan J Lamont
Journal:  BMC Vet Res       Date:  2012-03-08       Impact factor: 2.741

View more
  8 in total

1.  NLRC5 Mediates IL-6 and IL-1β Secretion in LX-2 Cells and Modulated by the NF-κB/Smad3 Pathway.

Authors:  Tao Xu; Ming-ming Ni; Cheng Huang; Xiao-ming Meng; Ying-hua He; Lei Zhang; Jun Li
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

2.  Sphk1 promotes ulcerative colitis via activating JAK2/STAT3 signaling pathway.

Authors:  Jiawen Liu; Bo Jiang
Journal:  Hum Cell       Date:  2019-10-12       Impact factor: 4.174

Review 3.  MHC class I transactivator NLRC5 in host immunity, cancer and beyond.

Authors:  Steven X Cho; Saptha Vijayan; Ji-Seung Yoo; Toshiyuki Watanabe; Ryota Ouda; Ning An; Koichi S Kobayashi
Journal:  Immunology       Date:  2020-08-03       Impact factor: 7.397

Review 4.  NLRC5 Functions beyond MHC I Regulation-What Do We Know So Far?

Authors:  Szilvia Benkő; Elek Gergő Kovács; Felix Hezel; Thomas A Kufer
Journal:  Front Immunol       Date:  2017-02-17       Impact factor: 7.561

5.  NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ.

Authors:  Peipei Luan; Weixia Jian; Xu Xu; Wenxin Kou; Qing Yu; Handan Hu; Dali Li; Wei Wang; Mark W Feinberg; Jianhui Zhuang; Yawei Xu; Wenhui Peng
Journal:  Nat Commun       Date:  2019-06-28       Impact factor: 14.919

6.  NLRC5 Serves as a Pro-viral Factor During Influenza Virus Infection in Chicken Macrophages.

Authors:  Shubhada K Chothe; Ruth H Nissly; Levina Lim; Gitanjali Bhushan; Ian Bird; Jessica Radzio-Basu; Bhushan M Jayarao; Suresh V Kuchipudi
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

7.  NLRC5 Deficiency Deregulates Hepatic Inflammatory Response but Does Not Aggravate Carbon Tetrachloride-Induced Liver Fibrosis.

Authors:  Akouavi Julite I Quenum; Akhil Shukla; Fjolla Rexhepi; Maryse Cloutier; Amit Ghosh; Thomas A Kufer; Sheela Ramanathan; Subburaj Ilangumaran
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 7.561

Review 8.  NLRC5: A Potential Target for Central Nervous System Disorders.

Authors:  Lu Zhang; Cui Jiao; Lingjuan Liu; Aiping Wang; Li Tang; Yi Ren; Peng Huang; Jie Xu; Dingan Mao; Liqun Liu
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.